AFRRI and Cleveland BioLabs (CBLI) Awarded $612K Grant

September 30, 2009 11:41 AM EDT

Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced that the Joint Science and Technology Office for Chemical and Biological Defense at the Defense Threat Reduction Agency of the Department of Defense awarded the Armed Forces Radiobiology Research Institute (AFRRI) a $612,000 grant to study, with technical assistance from the Company, select compounds within Cleveland BioLabs's Protectan 600 series for development as a radiation countermeasure for treatment of acute radiation syndrome.

Create E-mail AlertRelated Categories

Corporate News

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?